2026. Stratifying Cardiovascular–Kidney–Metabolic Syndrome by Metabolic Dysfunction-Associated Steatotic Liver Disease: A Pathophysiology-Anchored, India-Contextualized Framework for Node-Directed Pharmacotherapy. Diabzen. 5, 1 (Jul. 2026), 1–23.